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Background. Sputum examination can be useful in diagnosing the cause of pneumonia in adults but is less well established in 
children. We sought to assess the diagnostic utility of polymerase chain reaction (PCR) for detection of respiratory viruses and bac-
teria in induced sputum (IS) specimens from children hospitalized with severe or very severe pneumonia.
Methods. Among children aged 1–59 months, we compared organism detection by multiplex PCR in IS and nasopharyngeal/
oropharyngeal (NP/OP) specimens. To assess whether organism presence or density in IS specimens was associated with chest radi-
ographic evidence of pneumonia (radiographic pneumonia), we compared prevalence and density in IS specimens from children 
with radiographic pneumonia and children with suspected pneumonia but without chest radiographic changes or clinical or labora-
tory findings suggestive of pneumonia (nonpneumonia group).
Results. Among 4232 cases with World Health Organization–defined severe or very severe pneumonia, we identified 1935 (45.7%) 
with radiographic pneumonia and 573 (13.5%) with nonpneumonia. The organism detection yield was marginally improved with IS 
specimens (96.2% vs 92.4% for NP/OP specimens for all viruses combined [P = .41]; 96.9% vs 93.3% for all bacteria combined [P = .01]). 
After accounting for presence in NP/OP specimens, no organism was detected more frequently in the IS specimens from the radiographic 
pneumonia compared with the nonpneumonia cases. Among high-quality IS specimens, there were no statistically significant differences 
in organism density, except with cytomegalovirus, for which there was a higher quantity in the IS specimens from cases with radiographic 
pneumonia compared with the nonpneumonia cases (median cycle threshold value, 27.9 vs 28.5, respectively; P = .01).
Conclusions. Using advanced molecular methods with IS specimens provided little additional diagnostic information beyond 
that obtained with NP/OP swab specimens.
Keywords. induced sputum; PCR; pneumonia etiology; nasopharyngeal swab; community-acquired pneumonia.
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Although the World Health Organization (WHO) recommends 
empiric treatment for community-acquired pneumonia (CAP) 
in children [1], determining the causative pathogen is impor-
tant if empiric therapy fails and important at a population level 
to guide treatment and prevention strategies. However, deter-
mining the cause of pneumonia by sampling the lung directly 
through bronchoscopy or transthoracic lung aspiration is possi-
ble in only a subset of cases and requires technical expertise not 
available in most settings [2]. 
A definitive etiologic diagnosis can be made by isolating 
pathogens from blood or parapneumonic fluid, but yields are 
low (<10%) [3]. Gram stain or culture of a sputum specimen 
correlates well with blood isolation of Streptococcus pneumo-
niae (57% and 79%, respectively) in adults with pneumonia 
[4], about 75% of whom can produce a specimen adequate 
for bacterial pathogen identification [5, 6]. However, there is 
less experience using sputum specimens in children for eti-
ologic diagnosis because of the challenges posed by contam-
ination with upper respiratory tract secretions and frequent 
colonization of the upper respiratory tract with known res-
piratory pathogens, such as pneumococcus [7, 8]. Although 
upper respiratory tract specimens (eg, nasopharyngeal [NP] 
swab specimens) are often used for diagnostic purposes in 
children with respiratory viral and some bacterial infec-
tions, there is concern whether the results reflect the cause 
of pneumonia [9, 10].
Examination of induced sputum (IS) specimens for suspected 
Pneumocystis jirovecii or Mycobacterium tuberculosis in chil-
dren is useful and is now the standard of care [11, 12]. In studies 
of children with CAP in Finland [13, 14], New Caledonia [15], 
Kenya [16], and China [17], IS specimen collection was found 
to be well tolerated, and specimens were largely of good quality 
and with high frequencies of bacterial and viral putative path-
ogens. However, the conclusion about the significance of these 
pathogens as causes of pneumonia is limited because only the 
Kenya study included a control group.
Molecular diagnostic methods have the potential to 
improve our ability to detect small numbers of organisms in 
tissue and body fluids, thus making them an attractive poten-
tial approach for the diagnosis of pneumonia [18, 19]. Nucleic 
acid amplification tests can be used to detect nucleic acid 
from potentially all respiratory pathogens, are not depend-
ent on viable organisms or fastidious culture conditions, and 
are not as affected by prior exposure to antibiotics as con-
ventional culture methods. Using data from a large study of 
children hospitalized with pneumonia, we assessed the prev-
alence of pathogens in IS compared with nasopharyngeal/
oropharyngeal (NP/OP) specimens. In addition, to deter-
mine whether the presence or quantity of respiratory path-
ogens detected with polymerase chain reaction (PCR) in IS 
specimens was associated with clinical pneumonia status, we 
compared hospitalized children enrolled in the Pneumonia 
Etiology Research for Child Health (PERCH) study who had 
radiographic evidence of pneumonia (radiographic pneumo-
nia) with those who had a normal chest radiograph and a low 
likelihood of clinical pneumonia. The use of microbiological 
cultures of IS specimens for the diagnosis of childhood pneu-
monia is reported separately [20].
METHODS
Clinical Methods
The PERCH study sought to determine the cause of severe pneu-
monia in children aged 1–59 months living in developing areas 
[21]. The detailed methods of this multisite case-control study, 
including a description of case and control enrollment, have been 
published elsewhere [22, 23]. Briefly, in each of 9 sites in 7 coun-
tries (Dhaka and Matlab, Bangladesh; Basse, The Gambia; Kilifi, 
Kenya; Bamako, Mali; Soweto, South Africa; Sa Kaeo and Nakhon 
Phanom, Thailand; and Lusaka, Zambia), from August 2011 to 
January 2014, children presenting to study facilities with WHO-
defined severe or very severe pneumonia were evaluated for enroll-
ment using standardized criteria. Controls were randomly selected 
children from the community without severe or very severe pneu-
monia and were frequency matched for age (4 age strata) within 
2 weeks of the matched case enrollment. Blood, NP/OP swab 
specimens, and urine were collected from both cases and controls; 
blood cultures and IS specimens were also collected from cases.
IS specimen collection was attempted within 24 hours of hos-
pital admission for each PERCH case unless contraindicated. 
The methods for sputum induction are described elsewhere 
[24, 25]. In brief, participants were given a β2-agonist followed 
by nebulized hypertonic saline solution. A sterile closed-loop 
mucus extractor attached to a suction device was inserted 
through the nose into the nasopharynx. Suction was applied 
once the extractor was in the nasopharynx and was discontin-
ued before the extractor was removed. Secretions were flushed 
into a collection container using 5 mL of sterile normal saline.
Laboratory Methods
All laboratory methods were highly standardized across all 
study laboratories [25, 26]. Quantitative real-time PCR for 
respiratory pathogens was performed on IS and NP/OP spec-
imens, as described elsewhere [27].
Chest Radiograph
Chest radiographs from cases were classified as consolidation, 
other infiltrate, both consolidation and other infiltrate, normal, 
or uninterpretable by members of a panel of 14 radiologists and 
pediatricians, who were trained in the standardized interpreta-
tion of pediatric chest radiographs [28, 29].
Study Deﬁnitions
Because the WHO definitions for severe and very severe pneu-
monia are not specific [30], a proportion of children enrolled 
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as PERCH cases probably did not have true pneumonia. We 
therefore defined 2 subsets of PERCH cases: (1) children with 
radiographic evidence of pneumonia defined by the presence 
of consolidation and/or other infiltrate on chest radiographs, 
representing children who truly had infectious pneumonia, and 
(2) children with clinical and laboratory characteristics highly 
indicative of the absence of pneumonia, representing children 
enrolled into the case arm but with a very low likelihood of hav-
ing infectious pneumonia (ie, nonpneumonia group; Text Box 
1). Because IS specimens were not collected from controls, the 
nonpneumonia cases acted as “mock controls,” and this group 
was compared for similarity with PERCH control children.
Hypoxemia was defined as oxygen saturation <92% (or < 90% 
at elevations of >1200 meters) or receipt of supplemental oxy-
gen if a room air oxygen saturation reading was not available. 
A high-quality IS specimen was defined as a sputum specimen 
with <10 squamous epithelial cells per low-power field [25].
Statistical Analysis
To test the hypothesis that pathogens causing pneumonia will 
be detected more frequently in IS than in NP/OP specimens, 
we compared individual paired IS and NP/OP specimen results 
among cases with radiographic pneumonia, using McNemar’s 
χ2 test. We calculated additional pathogen detection from the 
IS specimen, over and above the NP/OP specimen, as the ratio 
(number of infections detected in either specimen divided by 
number of infections detected in the NP/OP specimen) minus 
1 and expressed as a percentage. The proportion of chest radio-
graphic–positive cases with IS specimen density higher or lower 
than NP/OP specimen density (difference, ≥1 log10 copies/mL) 
was evaluated using the 2-sided sign test.
To assess whether pathogen detection in IS specimens (using 
multiplex PCR) was associated with radiographic evidence of 
pneumonia, we compared pathogen prevalence in the IS spec-
imens of children with radiographic pneumonia and those 
without evidence of pneumonia (nonpneumonia) and calcu-
lated odds ratios and 95% confidence intervals (CIs), with and 
without adjustment for the presence of the pathogen on the NP/
OP specimen. We compared PCR cycle threshold (Ct) values 
(a semiquantitative measure of pathogen load) in IS specimens 
from radiographic pneumonia and nonpneumonia case groups, 
using the Wilcoxon rank sum test. To compare demographic 
and baseline characteristics of individuals between study 
groups, we calculated frequencies for categorical variables and 
median values with interquartile ranges (75th centile minus 
25th centile) for continuous variables. To evaluate the similar-
ity of our mock control group (ie, nonpneumonia cases) with 
true control children, we compared the prevalence of organisms 
detected in the NP/OP specimens and calculated odds ratios 
and 95% CIs. Odds ratios were adjusted for potential confound-
ing variables (eg, age, sex, site, and human immunodeficiency 
virus [HIV] status) where appropriate.
The majority of analyses involving IS specimens were 
restricted to high-quality specimens, those more likely to have 
originated from the lower respiratory tract [25]. The signif-
icance of differences between specimens or groups for the 28 
organisms evaluated was assessed using Bonferroni correction 
(0.05/28), so that were differences were considered statistically 
significant at P < .002.
Ethical Considerations
The study protocol was approved by the institutional review 
board or ethical review committee at each of the study site 
institutions and at Johns Hopkins Bloomberg School of Public 
Health. Parents or guardians of participants provided written 
informed consent.
RESULTS
Study Population
A total of 4232 cases with WHO-defined severe (n = 2862) or 
very severe (n = 1370) pneumonia and 5325 control children 
were enrolled during a 24-month period. IS specimens were 
collected from 3800 (89.8%) cases, including 94.8% (n = 2713) 
of those with severe pneumonia and 79.3% (n = 1087) with 
very severe pneumonia (Supplementary Table 1). Reasons for 
noncollection of IS specimens included presence of a contra-
indication (169 of 432; 39.1%), death (96 of 432; 22.2 %), intu-
bation (85 of 432; 19.7%), parent refusal (14 of 432; 3.2%), and 
other or unknown reason (68 of 432; 15.7%). The IS specimen 
collection procedure was generally well tolerated, but adverse 
consequences were reported in 13 cases (0.34% of procedures); 
the most common was a transient drop in oxygen saturation 
[31]. Of the 4232 cases enrolled in PERCH, 1935 (45.7%) had 
radiographic pneumonia, 573 (13.5%) were classified as non-
pneumonia, and 1724 (40.7%) fell into neither category (Table 
1). This analysis is restricted to a comparison of the 1935 cases 
with radiographic pneumonia, 573 nonpneumonia cases, and 
5325 controls.
The proportion cases with radiographic pneumonia var-
ied by site, from 31% at Matlab, Bangladesh, to 60% at Dhaka, 
Bangladesh, and Soweto, South Africa (Table 2). The proportion 
of nonpneumonia cases among those enrolled varied by site 
from none in Dhaka, Bangladesh and 4.5% of cases in Soweto, 
South Africa, to 31% enrolled from Kilifi, Kenya (Table 2). 
Compared with nonpneumonia cases, cases with radiographic 
pneumonia were more likely to be female (44% vs 36%; P < 
.001), have an abnormally high or low white blood cell count 
(51% vs 37%; P < .001), or be HIV positive (9% vs 1%; P < .001); 
malaria was more common in the nonpneumonia group (8% vs 
1%; P < .001) (Table 1). 
Characteristics used to distinguish radiographic pneumonia 
from nonpneumonia cases, such as hypoxemia (45% vs 6%), 
tachypnea for age (84% vs 51%), and the presence of crackles 
(69% vs 18%) differed as expected. Cases in the nonpneumonia 
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group were more likely to produce high-quality sputum speci-
mens (75% vs 67%; P < .001). The low number of cases classified 
as nonpneumonia in South Africa reflects the standard clinical 
practice at that site to administer oxygen to all children with 
a diagnosis of pneumonia (often without obtaining a room air 
oxygen saturation measurement), which led to a high percent-
age (75%) of cases meeting the study definition of hypoxemia. 
No cases met the definition of nonpneumonia at the Dhaka, 
Bangladesh site; 40% had a normal chest radiograph but all had 
other respiratory findings that excluded them from nonpneu-
monia status (Text Box 1).
Comparison of NP/OP and IS Specimen Findings
To determine the concordance of pathogen detection rates 
between NP/OP and IS specimens, and the added yield from 
testing IS specimens in addition to NP/OP specimens, we ana-
lyzed NP/OP swabs and IS specimens collected from the 1692 
cases admitted to the hospital with radiographic pneumonia from 
whom paired specimens were available. Of these 1692, 99% had 1 
or more pathogens identified on IS PCR; the median number of 
pathogens identified on PCR of IS or NP/OP was 4.  Among those 
with paired specimens, high quality IS specimens were available in 
1114 (65.8%). Using both NP/OP and high-quality IS specimens, 
bacteria were detected in 1080 (96.9%) specimens and viruses in 
1072 (96.2%) specimens. Overall, the IS specimens increased the 
number of cases with a virus, bacteria, or any organism detected 
by 4.1%, 3.9%, and 1.3%, respectively (Table 3). Restricting this 
analysis to cases <6 months of age slightly reduced the added ben-
efit (data not shown).
Among cases with radiographic pneumonia, pathogen 
detection by PCR was similar for high-quality IS specimens 
and NP/OP specimens for most pathogens; this is reflected 
Table  1. Clinical and Laboratory Features of Cases With Radiographic 
Pneumonia, Cases With Nonpneumonia, and Cases Excluded From the 
Analysis Data Seta
Feature
Cases, No. (%)b
P Valuec
Radiographic 
Pneumonia (n = 1935)
Nonpneumonia 
(n = 573)
Excluded 
(n = 1724)
Age (mo), 
median 
(IQR)
8.0 (13.0) 8.0 (16.0) 7.0 (13.0) .11
Age group
 1–11 mo 1229 (63.5) 348 (60.7) 1128 (65.4) .23
 1–5 mo 761 (39.3) 225 (39.3) 748 (43.4) .32
 6–11 mo 468 (24.2) 123 (21.5) 380 (22.0)
 12–59 mo 706 (36.5) 225 (39.3) 596 (34.6)
Female sex 859 (44.4) 207 (36.1) 750 (43.5) <.001
Feverd 1614 (83.4) 463 (80.8) 1373 (79.6) .15
WBC 
abnormalitye
932 (51.2) 202 (37.0) 729 (45.2) <.001
Malaria slide 
positive
20 (1.0) 44 (7.7) 29 (1.7) <.001
HIV infection 166 (8.6) 8 (1.4) 77 (4.5) <.001
High-quality IS 
specimenf
1166 (66.6) 398 (74.8) 1049 (69.2) <.001
Prior use of 
antibioticsg
1393 (79.5) 365 (68.6) 1122 (74.0) <.001
Tachypneah 1629 (84.4) 293 (51.1) 1545 (89.7)
Hypoxemiai 862 (44.6) 32 (5.6) 694 (40.4)
Oxygen 
requirement
271 (14.0) 13 (2.3) 233 (13.5)
Crackles 
at chest 
auscultation
1326 (69.0) 103 (18.0) 1287 (75.0)
Bacteremiaj 73 (3.8) 0 (0.0) 74 (4.4)
Abbreviations: CXR, chest radiograph; HIV, human immunodeficiency virus; IQR, interquar-
tile range (75th centile minus 25th centile); IS, induced sputum; WBC, white blood cell.
aRadiographic pneumonia was defined as radiographic evidence of pneumonia (consoli-
dation and/or other infiltrates); nonpneumonia, as normal chest radiograph, blood culture 
negative for pathogens, and either (1) a normal respiratory rate or no hypoxemia in the 
absence of crackles or (2) a normal respiratory rate and no hypoxemia in the presence of 
crackles. Excluded cases were those who did not meet either definition.
bData represent No. (%) of cases unless otherwise specified.
cP values for comparison between radiographic pneumonia and nonpneumonia groups 
(χ2 or Wilcoxon test); values are not presented for variables used to define nonpneumonia 
status.
dFever was defined as documented temperature of ≥38.0°C or fever in the past 48 hours 
as reported by caregiver.
eWBC count ≥15 or ≥13 × 109/L for children aged 1–11 or 12–59 months, respectively, or 
<5 × 109/L for children of any age.
fHigh-quality IS specimens were defined as <10 squamous epithelial cells per low-power 
field.
gPrior use of antibiotics was defined as positive serum bioassay results, antibiotic admin-
istration at the referral facility, or antibiotic administration before IS specimen collection at 
the study facility.
hTachypnea was defined as ≥60, ≥50, or ≥ 40 breaths per minute for children aged <2, 
2–11, or 12–59 months, respectively.
iHypoxemia was defined as (1) a room air pulse oximetric reading indicated oxygen 
saturation <90% at the 2 sites at elevation (Zambia and South Africa) or <92% at all other 
sites or (2) receipt of supplemental oxygen if a room air oxygen saturation reading was 
not available.
jMicrobiologically confirmed isolation of bacterial organism from sterile site (eg, blood or 
parapneumonic fluid).
Box 1. Deﬁnition of Nonpneumonia (“Mock Control”) Group
1. Enrollment into the PERCH study as a case with WHO-
defined severe or very severe pneumonia and
2. Normal chest radiographa and
3. Blood culture negative for pathogens and
4. In the absence of crackles:
a. Normal respiratory rateb or no hypoxemiac
5. In the presence of crackles:
a. Normal respiratory rate and no hypoxemiac
Abbreviations: PERCH, Pneumonia Etiology Research 
for Child Health; WHO, World Health Organization.aA 
normal chest radiograph was defined as no evidence of 
radiographic pneumonia (consolidation or other infil-
trate).bHypoxemia was defined as oxygen saturation <92% 
(<90% at higher altitudes sites, Zambia and South Africa) 
or supplemental oxygen requirement if a room air oxygen 
saturation value was not available.cNormal respiratory rate 
was defined as <60, <50, or <40 breaths per minute for chil-
dren aged <2, 2–11, or 12–59 months.
Downloaded from https://academic.oup.com/cid/article-abstract/64/suppl_3/S289/3858219
by guest
on 29 January 2018
Induced Sputum and the Diagnosis of Childhood Pneumonia • CID 2017:64 (Suppl 3) • S293
Ta
bl
e 
2.
 
Ch
ar
ac
te
ri
st
ic
s 
of
 R
ad
io
gr
ap
hi
c 
Pn
eu
m
on
ia
 a
nd
 N
on
pn
eu
m
on
ia
 G
ro
up
s 
by
 S
ite
a
C
ha
ra
ct
er
is
tic
C
as
es
, N
o.
 (%
)b
K
ili
fi,
 K
en
ya
 (n
 =
 6
34
)
B
as
se
, T
he
 G
am
bi
a 
(n
 =
 6
38
)
B
am
ak
o,
 M
al
i (
n 
=
 6
74
)
Lu
sa
ka
, Z
am
bi
a 
(n
 =
 6
17
)
S
ow
et
o,
 S
ou
th
 A
fr
ic
a 
(n
 =
 9
20
)
N
ak
ho
n 
P
ha
no
m
 a
nd
 
S
a 
K
ae
o,
 T
ha
ila
nd
 
(n
 =
 2
24
)
M
at
la
b,
 B
an
gl
ad
es
h 
(n
 =
 3
27
)
D
ha
ka
, B
an
gl
ad
es
h 
(n
 =
 1
98
)
R
P
N
o
n
-R
P
 
R
P
N
o
n
-R
P
R
P
N
o
n
-R
P
R
P
N
o
n
-R
P
R
P
N
o
n
-R
P
R
P
N
o
n
-R
P
R
P
N
o
n
-R
P
R
P
N
o
n
-R
P
A
ll 
ca
se
s
28
4 
(4
4.
8)
19
5 
(3
0.
8)
29
0 
(4
5.
5)
10
1 
(1
5.
8)
25
3 
(3
7.
5)
10
0 
(1
4.
8)
26
6 
(4
3.
1)
67
 (1
0.
9)
52
4 
(6
0.
0)
41
 (4
.5
)
99
 (4
4.
2)
31
 (1
3.
8)
10
1 
(3
0.
9)
38
 (1
1.
6)
11
8 
(6
0.
0)
0 
(0
.0
)
A
ge
 (m
o)
, 
m
ed
ia
n 
(IQ
R
)
10
.0
 (1
4.
0)
c
13
.0
 (1
9.
0)
8.
5 
(1
3.
0)
7.
0 
(1
7.
0)
8.
0 
(1
0.
0)
8.
5 
(1
2.
5)
5.
0 
(9
.0
)
4.
0 
(8
.0
)
6.
0 
(1
0.
0)
4.
0 
(6
.0
)
15
.0
 (2
1.
0)
13
.0
 (1
6.
0)
12
.0
 (1
7.
0)
c
7.
0 
(2
1.
0)
12
.0
 (1
4.
0)
0 
(0
.0
)
A
ge
 g
ro
up
 
1–
11
 m
o
15
6 
(5
4.
9)
91
 (4
6.
7)
18
0 
(6
2.
1)
66
 (6
5.
3)
16
3 
(6
4.
4)
64
 (6
4.
0)
20
0 
(7
5.
2)
57
 (8
5.
1)
39
2 
(7
4.
8)
32
 (7
8.
0)
38
 (3
8.
4)
14
 (4
5.
2)
47
 (4
6.
5)
24
 (6
3.
2)
53
 (4
4.
9)
0 
(0
.0
)
 
1–
5 
m
o
90
 (3
1.
7)
55
  (
28
.2
)
10
9 
(3
7.
6)
45
 (4
4.
6)
10
2 
(4
0.
3)
36
 (3
6.
0)
13
7 
(5
1.
5)
42
 (6
2.
7)
25
4 
(4
8.
5)
24
 (5
8.
5)
19
 (1
9.
2)
6 
(1
9.
4)
25
 (2
4.
8)
17
 (4
4.
7)
25
 (2
1.
2)
0 
(0
.0
)
 
6–
11
 m
o
66
 (2
3.
2)
36
 (1
8.
5)
71
 (2
4.
5)
21
 (2
0.
8)
61
 (2
4.
1)
28
 (2
8.
0)
63
 (2
3.
7)
15
 (2
2.
4)
13
8 
(2
6.
3)
8 
(1
9.
5)
19
 (1
9.
2)
8 
(2
5.
8)
22
 (2
1.
8)
7 
(1
8.
4)
28
 (2
3.
7)
0 
(0
.0
)
 
12
–5
9 
m
o
12
8 
(4
5.
1)
10
4 
(5
3.
3)
11
0 
(3
7.
9)
35
 (3
4.
7)
90
 (3
5.
6)
36
 (3
6.
0)
66
 (2
4.
8)
10
 (1
4.
9)
13
2 
(2
5.
2)
9 
(2
2.
0)
61
 (6
1.
6)
17
 (5
4.
8)
54
 (5
3.
5)
14
 (3
6.
8)
65
 (5
5.
1)
0 
(0
.0
)
B
ac
te
re
m
ia
d
9 
(3
.2
)
0 
(0
.0
)
14
 (4
.9
)
0 
(0
.0
)
16
 (6
.3
)
0 
(0
.0
)
14
 (5
.3
)
0 
(0
.0
)
15
 (2
.9
)
0 
(0
.0
)
3 
(3
.0
)
0 
(0
.0
)
0 
(0
.0
)
0 
(0
.0
)
2 
(1
.7
)
0 
(0
.0
)
Ta
ch
yp
ne
ae
22
4 
(7
8.
9)
87
 (4
4.
6)
26
4 
(9
1.
0)
54
 (5
3.
5)
21
5 
(8
5.
0)
66
 (6
6.
0)
24
5 
(9
2.
5)
40
 (6
2.
5)
39
6 
(7
7.
6)
11
 (2
6.
8)
75
 (8
0.
6)
18
 (5
8.
1)
93
 (9
2.
1)
17
 (4
4.
7)
11
7 
(9
9.
2)
0 
(0
.0
)
H
yp
ox
em
ia
f
10
7 
(3
7.
8)
12
  (
6.
2)
33
 (1
1.
4)
0 
(0
.0
)
14
0 
(5
5.
3)
5 
(5
.0
)
13
3 
(5
0.
2)
4 
(6
.0
)
39
8 
(7
6.
1)
11
 (2
7.
5)
29
 (2
9.
3)
0 
(0
.0
)
3 
(3
.0
)
0 
(0
.0
)
19
 (1
6.
1)
0 
(0
.0
)
C
ra
ck
le
s
13
4 
(4
7.
3)
16
 (8
.2
)
23
4 
(8
1.
0)
30
 (2
9.
7)
18
6 
(7
3.
5)
15
 (1
5.
0)
14
7 
(5
5.
3)
12
 (1
7.
9)
34
7 
(6
7.
8)
9 
(2
2.
0)
68
 (6
8.
7)
3 
(9
.7
)
93
 (9
2.
1)
18
 (4
7.
4)
11
7 
(9
9.
2)
0 
(0
.0
)
H
ig
h-
qu
al
ity
 IS
 
sp
ec
im
en
g
23
3 
(8
6.
9)
15
7 
(8
5.
8)
19
7 
(7
4.
3)
67
 (6
9.
1)
12
6 
(5
9.
4)
50
 (5
6.
8)
19
4 
(8
2.
2)
48
 (8
1.
4)
20
2 
(4
3.
2)
22
 (5
6.
4)
72
 (9
0.
0)
26
 (9
6.
3)
69
 (6
8.
3)
28
 (7
3.
7)
73
 (6
1.
9)
0 
(0
.0
)
Pr
io
r 
us
e 
of
 
an
tib
io
tic
sh
25
2 
(9
3.
7)
c
15
8 
(8
6.
3)
60
 (2
2.
6)
23
 (2
3.
7)
17
6 
(8
3.
0)
c
55
 (6
2.
5)
23
6 
(9
8.
7)
58
 (9
6.
7)
43
4 
(9
2.
7)
37
 (9
4.
9)
74
 (9
2.
5)
c
21
 (7
7.
8)
43
 (4
2.
6)
13
 (3
4.
2)
11
8 
(1
00
)
0 
(0
.0
)
A
bb
re
vi
at
io
ns
: I
Q
R
, i
nt
er
qu
ar
til
e 
ra
ng
e 
(7
5t
h 
ce
nt
ile
 m
in
us
 2
5t
h 
ce
nt
ile
); 
IS
, i
nd
uc
ed
 s
pu
tu
m
; N
on
-R
P,
 n
on
-r
ad
io
gr
ap
hi
c 
pn
eu
m
on
ia
; R
P,
 r
ad
io
gr
ap
hi
c 
pn
eu
m
on
ia
.
a R
ad
io
gr
ap
hi
c 
pn
eu
m
on
ia
 w
as
 d
efi
ne
d 
as
 ra
di
og
ra
ph
ic
 e
vi
de
nc
e 
of
 p
ne
um
on
ia
 (c
on
so
lid
at
io
n 
an
d/
or
 o
th
er
 in
fil
tr
at
es
); 
no
np
ne
um
on
ia
, a
s 
no
rm
al
 c
he
st
 ra
di
og
ra
ph
, b
lo
od
 c
ul
tu
re
 n
eg
at
iv
e 
fo
r p
at
ho
ge
ns
, a
nd
 e
ith
er
 (1
) a
 n
or
m
al
 re
sp
ira
to
ry
 ra
te
 o
r n
o 
hy
po
xe
m
ia
 
in
 t
he
 a
bs
en
ce
 o
f 
cr
ac
kl
es
 o
r 
(2
) a
 n
or
m
al
 r
es
pi
ra
to
ry
 r
at
e 
an
d 
no
 h
yp
ox
em
ia
 in
 t
he
 p
re
se
nc
e 
of
 c
ra
ck
le
s.
b P
er
ce
nt
ag
es
 fo
r 
ra
di
og
ra
ph
ic
 p
ne
um
on
ia
 a
nd
 n
on
pn
eu
m
on
ia
 a
re
 b
as
ed
 o
n 
to
ta
l n
um
be
r 
of
 c
as
es
 a
t 
th
e 
si
te
; p
er
ce
nt
ag
es
 fo
r 
ch
ar
ac
te
ris
tic
s 
ba
se
d 
on
 t
ot
al
 n
um
be
r 
in
di
ca
te
d 
in
 c
or
re
sp
on
di
ng
 c
ol
um
n.
c S
ig
ni
fic
an
t 
di
ffe
re
nc
e 
be
tw
ee
n 
ra
di
og
ra
ph
ic
 p
ne
um
on
ia
 a
nd
 n
on
pn
eu
m
on
ia
 g
ro
up
s 
at
 t
he
 s
ite
 (n
ot
 r
ep
or
te
d 
fo
r 
ba
ct
er
em
ia
, t
ac
hy
pn
ea
, h
yp
ox
em
ia
, o
r 
cr
ac
kl
es
 b
ec
au
se
 t
he
y 
ar
e 
pa
rt
 o
f 
th
e 
no
np
ne
um
on
ia
 d
efi
ni
tio
n)
.
d M
ic
ro
bi
ol
og
ic
al
ly
 c
on
fir
m
ed
 is
ol
at
io
n 
of
 b
ac
te
ria
l o
rg
an
is
m
 f
ro
m
 s
te
ril
e 
si
te
 (e
g,
 b
lo
od
 o
r 
pa
ra
pn
eu
m
on
ic
 fl
ui
d)
.
e T
ac
hy
pn
ea
 d
efi
ne
d 
as
 ≥
60
, ≥
50
, o
r 
≥ 
40
 b
re
at
hs
 p
er
 m
in
ut
e 
fo
r 
ch
ild
re
n 
ag
ed
 <
2,
 2
–1
1,
 o
r 
12
–5
9 
m
on
th
s,
 r
es
pe
ct
iv
el
y.
f H
yp
ox
em
ia
 w
as
 d
efi
ne
d 
as
 (1
) a
 ro
om
 a
ir 
pu
ls
e 
ox
im
et
ric
 re
ad
in
g 
in
di
ca
te
d 
ox
yg
en
 s
at
ur
at
io
n 
<
90
%
 a
t t
he
 2
 s
ite
s 
at
 e
le
va
tio
n 
(Z
am
bi
a 
an
d 
S
ou
th
 A
fr
ic
a)
 o
r <
92
%
 a
t a
ll 
ot
he
r s
ite
s 
or
 (2
) r
ec
ei
pt
 o
f s
up
pl
em
en
ta
l o
xy
ge
n 
if 
a 
ro
om
 a
ir 
ox
yg
en
 s
at
ur
at
io
n 
re
ad
in
g 
w
as
 n
ot
 a
va
ila
bl
e.
g H
ig
h-
qu
al
ity
 IS
 s
pe
ci
m
en
s 
w
er
e 
de
fin
ed
 a
s 
<
10
 s
qu
am
ou
s 
ep
ith
el
ia
l c
el
ls
 p
er
 lo
w
-p
ow
er
 fi
el
d.
h P
rio
r 
us
e 
of
 a
nt
ib
io
tic
s 
de
fin
ed
 a
s 
po
si
tiv
e 
se
ru
m
 b
io
as
sa
y 
re
su
lts
, a
nt
ib
io
tic
 a
dm
in
is
tr
at
io
n 
at
 t
he
 r
ef
er
ra
l f
ac
ili
ty
, a
nt
ib
io
tic
 a
dm
in
is
tr
at
io
n 
be
fo
re
 IS
 s
pe
ci
m
en
 c
ol
le
ct
io
n 
at
 t
he
 s
tu
dy
 fa
ci
lit
y.
Downloaded from https://academic.oup.com/cid/article-abstract/64/suppl_3/S289/3858219
by guest
on 29 January 2018
S294 • CID 2017:64 (Suppl 3) • Thea et al
by the moderate-to-high agreement between NP/OP and IS 
specimens (Table  3). A  similar pattern was also observed 
comparing high-quality IS and NP/OP specimens from 
nonpneumonia cases (Supplementary Table  2). The added 
yield of an IS specimen for identifying a pathogen in cases 
with radiographic pneumonia varied by organism from 
4.8% (95% CI, 3.4%–6.8%; Moraxella catarrhalis) to 81.8% 
(31.3%–212.0%; Salmonella species). Because the added 
yield calculation can be misleading with small sample sizes 
(eg, the 81.8% for Salmonella species reflects a difference of 
8 vs 9 detections in NP/OP vs IS specimens), it is useful to 
visualize the pattern of detection of different pathogens by 
different specimen types. 
As seen in Figure 1, the NP/OP specimens detected the 
majority of infections for most organisms. However, for 
certain organisms, IS specimens seem superior to NP/OP 
specimens (eg, in cases with radiographic pneumonia, parain-
fluenza 1 was detected from IS specimens alone in 2.8% vs 
0.5% for NP/OP specimens alone). An analysis stratified by 
pneumonia severity (severe or very severe) and age <6 months 
showed pathogen detection rates from NP/OP and IS spec-
imens very similar to those indicated in Table 3 (data not 
Table 3. PCR Pathogen Detection in Paired NP/OP Swab and IS Specimens From 1114 Hospitalized Children (Aged 1–59 Months) With Radiographic 
Pneumonia 
Pathogen
Cases, No. (%)
Odds Ratio (95% 
CI)b P Valueb
Increase With Use 
of IS Specimens 
(95% CI), %c
Agreement 
Between NP/OP 
and IS  
Specimens, %
Both NP/OP and IS 
Specimens Positivea
Only NP/OP 
Specimens 
Postitive
Only IS 
Specimens 
Positive
Bordetella pertussis 7 (0.6) 1 (0.1) 3 (0.3) 3.00 (.95–9.52) .63 37.5 (7.9–154.3) 99.6
Chlamydophila pneumoniae 7 (0.6) 8 (0.7) 5 (0.5) 0.63 (.35–1.11) .58 33.3 (10.6–97.7) 98.8
Haemophilus influenzae 527 (47.7) 116 (10.5) 66 (6.0) 0.57 (.49–.66) < .001d 10.3 (7.9–13.3) 83.5
H. influenzae type b 16 (1.5) 9 (0.8) 6 (0.5) 0.67 (.39–1.13) .61 24.0 (8.8–61.4) 98.6
Moraxella catarrhalis 623 (56.4) 125 (11.3) 36 (3.3) 0.29 (.24–.35) <.001d 4.8 (3.4–6.8) 85.4
Mycoplasma pneumoniae 14 (1.3) 4 (0.4) 12 (1.1) 3.00 (1.68–5.34) .08 66.7 (30.2–145.4) 98.5
Pneumocystis jirovecii 65 (5.9) 31 (2.8) 29 (2.6) 0.94 (.72–1.21) .90 30.2 (19.5–46.5) 94.6
Staphylococcus aureus 96 (8.7) 66 (6.0) 42 (3.8) 0.64 (.52–.78) .03 25.9 (18.2–36.8) 90.2
Streptococcus pneumoniae 741 (67.1) 77 (7.0) 40 (3.6) 0.52 (.43–.63) <.001d 4.9 (3.5–6.8) 89.4
Salmonella species 3 (0.3) 8 (0.7) 9 (0.8) 1.13 (.69–1.83) >.99 81.8 (31.3–212.0) 98.5
Adenovirus 89 (8.1) 30 (2.7) 54 (4.9) 1.80 (1.43–2.26) .01 45.4 (32.5–63.3) 92.3
Bocavirus 76 (6.9) 71 (6.5) 79 (7.2) 1.11 (.94–1.31) .57 53.7 (40.5–71.2) 86.3
CMV 476 (43.4) 107 (9.8) 84 (7.7) 0.79 (.68–.91) .11 14.4 (11.4–18.2) 82.6
HCoV 229E 9 (0.8) 6 (0.5) 5 (0.5) 0.83 (.45–1.53) >.99 33.3 (10.6–97.7) 99.0
HCoV OC43 17 (1.6) 4 (0.4) 14 (1.3) 3.50 (1.99–6.17) .03 66.7 (32.2–136.9) 98.4
HCoV NL63 13 (1.2) 5 (0.5) 5 (0.5) 1.00 (.53–1.88) >.99 27.8 (9.0–79.2) 99.1
HCoV HKU1 16 (1.5) 8 (0.7) 6 (0.5) 0.75 (.44–1.29) .79 25.0 (9.2–64.3) 98.7
HMPV 89 (8.1) 28 (2.6) 39 (3.6) 1.39 (1.09–1.78) .22 33.3 (22.8–48.5) 93.9
Influenza A 34 (3.1) 7 (0.6) 5 (0.5) 0.71 (.4–1.28) .77 12.2 (4.2–32.2) 98.9
Influenza B 12 (1.1) 0 (0.0) 3 (0.3) N/A .25 25.0 (5.6–94.7) 99.7
Influenza C 4 (0.4) 4 (0.4) 1 (0.1) 0.25 (.08–.76) .38 12.5 (.6–97.4) 99.5
Parainfluenza 1 52 (4.8) 5 (0.5) 31 (2.8) 6.20 (3.83–10.04) <.001e 54.4 (34.3–85.9) 96.7
Parainfluenza 2 7 (0.6) 7 (0.6) 11 (1.0) 1.57 (.97–2.55) .48 78.6 (33.4–183.5) 98.4
Parainfluenza 3 55 (5.0) 11 (1.0) 19 (1.7) 1.73 (1.18–2.52) .20 28.8 (16.7–49.1) 97.3
Parainfluenza 4 20 (1.8) 13 (1.2) 6 (0.5) 0.46 (.28–.76) .17 18.2 (6.9–45.4) 98.3
PV/EV 51 (4.6) 33 (3.0) 55 (5.0) 1.67 (1.34–2.08) .02 65.5 (46.0–93.2) 92.0
Rhinovirus 164 (15.0) 76 (6.9) 72 (6.6) 0.95 (.8–1.12) .81 30.0 (22.8–39.3) 86.5
RSV 246 (22.4) 50 (4.6) 27 (2.5) 0.54 (.43–.69) .01 9.1 (6.0–13.7) 93.0
Any bacteria 1019 (91.4) 20 (1.8) 41 (3.7) 2.05 (1.56–2.69) .01 3.9 (2.9–5.4) 94.5
Any virus 979 (87.8) 51 (4.6) 42 (3.8) 0.82 (.67–1.01) .41 4.1 (3.0–5.6) 91.7
Any pathogen 1089 (97.7) 6 (0.5) 14 (1.3) 2.33 (1.43–3.8) .12 1.3 (.7–2.2) 98.2
Abbreviations: CI, confidence interval; CMV, cytomegalovirus; HCoV, human coronavirus; HMPV, human metapneumovirus A/B; IS, induced sputum; NP/OP, nasopharyngeal/oropharyngeal; 
PCR, polymerase chain reaction; PV/EV, parechovirus/enterovirus; RSV, respiratory syncytial virus. 
aCalculated among cases with radiographic pneumonia and available NP/OP specimens and high-quality IS specimens for each pathogen (n = 1114); some cases were missing data for certain 
pathogens (≤20 cases per pathogen). Radiographic evidence of pneumonia was defined as consolidation and/or other infiltrates.
bOdds ratio and P values were obtained with McNemar’s χ2 test. Odds ratios were calculated as the ratio of the discordant pairs (results for IS positive and NP/OP negative/results for NP/
OP positive and IS negative).
cPercentage increase calculated as ratio (No. of infections detected with either specimen/No. of infections detected with NP/OP specimen) minus 1, expressed as a percentage.
dThe presence in NP/OP specimens alone is significantly greater than that in IS specimens alone (P < .002).
eThe presence in IS specimens alone is significantly greater than that in NP/OP specimens alone (P < .002).
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shown). To assess whether the added yield of the IS specimen 
was related to collection of a sputum specimen per se or to 
collection of an additional respiratory specimen of any type, 
we compared the added yield of low-quality IS specimens (ie, 
those presumably from, or contaminated by, secretions from 
the upper respiratory tract) with the yield of NP/OP speci-
mens. The added yield of low-quality IS specimens was similar 
(Figure 1 vs Supplementary Figure 1).
There was no difference in the prevalence or the density of 
P. jirovecii by IS or NP/OP specimens among cases with radio-
graphic pneumonia (Table 3; Supplementary Table 3). Among 
HIV-positive children with radiographic pneumonia, the 
overall P. jirovecii detection rate was higher (19.7%) than in all 
HIV-negative cases with radiographic pneumonia (10.6%). In 
the latter group of HIV-negative children, there was a higher 
prevalence of P. jirovecii (17% vs 9%; P = .01) among children 
who were severely malnourished (weight for age less than −3 
z-scores below the median of the WHO child growth stand-
ards) than among those who were not. There was little added 
value in seeking the detection of P. jirovecii in IS versus NP/
OP specimens. Among 81 HIV-positive children with radio-
graphic pneumonia, P. jirovecii was detected in both IS and NP/
OP specimens in 13 cases, IS specimens alone in 2, and NP/
OP specimens alone in only 1. This represents an increase in 
yield of only 1% in the detection of P. jirovecii when assessing IS 
specimens in addition to NP/OP specimens (15 of 81 [18.5%] 
vs 14 of 81 [17.3%]).
Among cases with radiographic pneumonia, pathogen den-
sity in either IS or NP/OP specimens did not show a consist-
ent pattern across pathogens. As indicated by the proportion 
of cases with a difference in PCR density >1 log10 copies/mL, 
the density was greater in the IS specimen than in the NP/OP 
specimen only for parainfluenza 1, and greater in the NP/OP 
specimen for 3 organisms (Haemophilus influenzae, M. catarrh-
alis, and S. pneumoniae) (Supplementary Table 3).
Viral and Bacterial Organisms Identified by PCR of IS Specimens in 
Radiographic Pneumonia and Nonpneumonia Case Groups
To assess whether organism detection in IS specimens was 
associated with radiographic pneumonia, we compared its 
prevalence in the IS specimens from radiographic pneumo-
nia and nonpneumonia case groups, restricting the analysis to 
high-quality IS specimens. For 4 organisms (H. influenzae, M. 
pneumoniae, parainfluenza 1, and respiratory syncytial virus 
[RSV]), detection in the IS specimen was associated with radi-
ographic pneumonia case status; however, this association was 
no longer significant when accounting for the presence of the 
pathogen in the NP/OP specimen (Table 4). That is to say, no 
Figure 1. Multiplex polymerase chain reaction (PCR) pathogen detection in paired nasopharyngeal/oropharyngeal (NP/OP) swab and induced sputum (IS) specimens from 
1114 children aged 1–59 months, hospitalized with radiographic evidence of pneumonia (consolidation and/or other infiltrates) and with a high-quality IS specimen available. 
Gray bars represent pathogen detected in both IS and NP/OP specimens; black bars, pathogen detected in NP/OP but not IS specimens; and hatched bars, pathogen detected 
in IS but not NP/OP specimens. High-quality IS specimens were defined as <10 squamous epithelial cells per low-power field; radiographic evidence of pneumonia was 
defined as consolidation and/or other infiltrates. Abbreviations: CMV, cytomegalovirus; HCoV, human coronavirus; HMPV, human metapneumovirus A/B; PV/EV, parechovirus/
enterovirus; RSV, respiratory syncytial virus.
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organism was found significantly more frequently in the IS 
specimen from cases with radiographic pneumonia compared 
with nonpneumonia cases. However, given the close correlation 
in presence of organisms between IS and NP/OP specimens 
(Supplementary Table 2), the presence of the above 4 organisms 
in either the IS or NP/OP specimen was significantly associ-
ated with radiographic pneumonia status compared with non-
pneumonia status. An analysis stratified by pneumonia severity 
(severe and very severe) and age <6 months showed very similar 
results (Supplementary Tables 4a and 4b).
To test the hypothesis that organism density should be 
higher in IS specimens from cases with radiographic pneu-
monia than nonpneumonia cases if the IS specimen is more 
closely reflective of the cause of pneumonia, we compared 
median Ct values for each organism detected with IS speci-
men PCR. Among high-quality IS specimens, there were no 
statistically significant differences in organism density in the IS 
specimens from cases with radiographic pneumonia compared 
with nonpneumonia cases, with the exception of a marginally 
significant difference for cytomegalovirus (median Ct, 27.9 vs 
28.5; P = .01) (Figure 2). Findings were similar among infants 
aged <6 months (data not shown), with the only difference 
being greater S. pneumoniae density in the nonpneumonia 
group (median Ct, 27.0 for radiographic pneumonia vs 25.6 for 
nonpneumonia cases; P = .002).
We compared organism detection in the NP/OP speci-
mens between the nonpneumonia cases and the commu-
nity controls to assess whether our mock control group (ie, 
Table 4. PCR Pathogens Detection in High-Quality IS Specimens From Cases With Radiographic Pneumonia or Nonpneumonia
Pathogen
Cases, No. (%)a aOR (95% CI)b
Radiographic 
Pneumonia 
(n = 1166)
Nonpneumonia 
(n = 398)
Not Adjusted for 
NP/OP
Adjusted for  
NP/OP)
Bordetella pertussis 10 (0.90) 4 (1.0) 0.66 (.20–2.21) 0.77 (.14–4.21)
Chlamydophila pneumoniae 12 (1.1) 4 (1.0) 0.74 (.22–2.42) 0.64 (.18–2.38)
Haemophilus influenzae 600 (53.5) 168 (43.2) 1.33 (1.03–1.71)c 1.04 (.75–1.45)
H. influenzae type b 22 (2.0) 8 (2.1) 0.85 (.36–2.00) 1.07 (.36–3.16)
Moraxella catarrhalis 672 (59.9) 258 (66.3) 0.82 (.63–1.07) 0.87 (.62–1.24)
Mycoplasma pneumoniae 26 (2.3) 2 (0.5) 5.37 (1.24–23.18)c 4.46 (.86–23.08)
Pneumocystis jirovecii 94 (8.4) 20 (5.1) 1.24 (.73–2.09) 1.03 (.54–1.98)
Staphylococcus aureus 140 (12.5) 46 (11.8) 0.73 (.50–1.08) 0.87 (.55–1.40)
Streptococcus pneumoniae 795 (70.9) 279 (71.7) 0.98 (.75–1.29) 0.98 (.66–1.44)
Salmonella species 12 (1.1) 5 (1.3) 0.66 (.21–2.03) 0.53 (.16–1.70)
Adenovirus 149 (13.2) 58 (14.8) 0.72 (.51–1.02) 0.74 (.47–1.17)
Bocavirus 160 (14.3) 63 (16.2) 0.85 (.61–1.19) 0.82 (.56–1.21)
CMV 572 (50.8) 204 (52.2) 0.82 (.64, 1.05) 0.69 (.50–.95)c
HCoV 229E 14 (1.3) 5 (1.3) 1.03 (.35–2.99) 0.69 (.18–2.66)
HCoV OC43 32 (2.9) 13 (3.3) 0.81 (.40–1.61) 1.24 (.42–3.68)
HCoV NL63 18 (1.6) 12 (3.1) 0.36 (.15–.85)c 0.31 (.08–1.20)
HCoV HKU1 23 (2.1) 8 (2.1) 0.84 (.36–2.00) 0.43 (.13–1.38)
HMPV 133 (11.9) 41 (10.5) 1.26 (.85–1.86) 0.71 (.42–1.21)
Influenza A 39 (3.5) 19 (4.9) 0.69 (.38–1.25) 0.48 (.17–1.38)
Influenza B 15 (1.3) 11 (2.8) 0.59 (.26–1.34) 2.13 (.23–20.00)
Influenza C 5 (0.5) 4 (1.0) 0.23 (.06–.95)c 0.09 (.01–.99)c
Parainfluenza 1 84 (7.5) 18 (4.6) 2.00 (1.14–3.52)c 2.17 (.96–4.91)
Parainfluenza 2 19 (1.7) 4 (1.0) 1.83 (.61–5.51) 2.74 (.73–10.31)
Parainfluenza 3 75 (6.7) 21 (5.4) 1.17 (.70–1.97) 1.18 (.53–2.60)
Parainfluenza 4 27 (2.4) 10 (2.6) 0.85 (.39–1.86) 0.52 (.17–1.57)
PV/EV 109 (9.7) 43 (11.0) 0.92 (.62–1.35) 1.03 (.64–1.65)
Rhinovirus 243 (21.7) 92 (23.7) 0.79 (.59–1.05) 0.78 (.54–1.12)
RSV 279 (24.8) 60 (15.3) 2.08 (1.51–2.86)d 1.08 (.61–1.89)
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; CMV, cytomegalovirus; HCoV, human coronavirus; HMPV, human metapneumovirus A/B; IS, induced sputum; NP/OP, naso-
pharyngeal/oropharyngeal specimen results; PCR, polymerase chain reaction; PV/EV, parechovirus/enterovirus; RSV, respiratory syncytial virus.
aDenominators for percentages represent the number of children with available IS specimen results for each pathogen. Some cases had data missing for certain pathogens (<20 cases 
per pathogen). Radiographic pneumonia was defined as radiographic evidence of pneumonia (consolidation and/or other infiltrates); nonpneumonia, as normal chest radiograph, blood 
culture negative for pathogens, and either (1) a normal respiratory rate or no hypoxemia in the absence of crackles or (2) a normal respiratory rate and no hypoxemia in the presence of 
crackles.
bAll odds ratios adjusted for age, sex, site, and human immunodeficiency virus status.
cP < .05. 
dP < .002.
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nonpneumonia group) was similar to the community control 
group (Supplementary Table 5). Accounting for multiple com-
parisons, we found that some pathogens were identified less 
frequently among nonpneumonia cases (mock control group) 
than among the true controls (adjusted odds ratio for M. 
catarrhalis, 0.63 [95% CI, .51–.78]; P. jirovecii, 0.45 [.29–.70]); 
alternatively, some were more commonly found in nonpneu-
monia cases (adjusted odds ratio for influenza A, 3.32 [95% CI, 
1.93–5.69]; influenza B, 4.07 [CI, 2.14–7.72]; parainfluenza 1, 
4.66 [2.83–7.68]; RSV, 5.94 [4.34–8.12]).
DISCUSSION
Obtaining an uncontaminated diagnostic specimen from the 
lung in children with pneumonia would significantly enhance 
clinical case management, as well as our understanding of the 
microbiological cause of the disease. Although ideal in theory, 
this is quite difficult to establish in practice. In the current large 
study of childhood pneumonia etiology, which used highly 
standardized methods across 9 sites, we found generally good 
agreement between NP/OP and IS specimens in the detection 
of common respiratory pathogens with PCR and no clear diag-
nostic benefit of IS specimens. At a population level, multiplex 
PCR of IS specimens to identify respiratory organisms is likely 
to contribute little to our understanding of the etiology of pneu-
monia, beyond the information provided by NP/OP specimens.
In a recent study reported by Zar et al [32], in which chil-
dren hospitalized with pneumonia were investigated using both 
NP and IS specimens and laboratory methods comparable to 
those used in the PERCH study, a proportion of pneumonia 
cases were detected in the IS specimens only. We found similar 
Figure 2. Cycle threshold (Ct) values in induced sputum (IS) specimens of 28 pathogens among cases with radiographic evidence of pneumonia (n = 1166) and those in 
the nonpneumonia group (n = 398) who had a high-quality IS specimen available. Radiographic evidence of pneumonia was defined as consolidation and/or other infiltrates. 
Nonpneumonia was defined as a normal chest radiograph, blood culture negative for pathogens, and either (1) a normal respiratory rate or no hypoxemia in the absence of 
crackles or (2) a normal respiratory rate and no hypoxemia in the presence of crackles. Diamonds represent group means; boxes, interquartile ranges; vertical lines through 
boxes, group medians; whiskers, 95% confidence intervals; and numbers on right axis, cases with positive results. *Significant difference (P < .05) in density between radio-
graphic pneumonia and nonpneumonia groups. Abbreviations: CMV, cytomegalovirus; HCoV, human coronavirus; HMPV, human metapneumovirus A/B; PV/EV, parechovirus/
enterovirus; RSV, respiratory syncytial virus. 
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results; however, the fact that the added yield of high-quality 
IS specimens (ie, presumably those from the lower respiratory 
tract) was similar to that of low-quality IS specimens (ie, pre-
sumably those comprising or contaminated by upper respira-
tory tract secretions) suggests that some of the “added yield” 
of IS specimens may be related to collection of an additional 
specimen from the upper respiratory tract, but not collection of 
a sputum specimen specifically. We could have more adequately 
assessed this hypothesis had we collected a second NP/OP spec-
imen and compared results from 1 versus 2 specimens.
Although the prevalence of several organisms was higher 
in the IS specimens from cases with radiographic pneumonia 
than in those from the nonpneumonia cases, a similar trend 
was observed when comparing NP/OP specimens from non-
pneumonia cases and controls, so the IS specimen does not add 
inferential value here. Furthermore, organism detection by IS 
specimen PCR was not associated with radiographic pneumo-
nia compared with nonpneumonia, after controlling for the 
organism’s presence in NP/OP specimens. Notably, this com-
parator group consisted of children who met the WHO case 
definition of severe pneumonia despite normal chest radio-
graphic findings and the absence of many pneumonia clinical 
characteristics, so it does not represent a true control group 
(ie, nonhospitalized children). The observation that the NP/
OP specimens from nonpneumonia cases were enriched for 
certain respiratory pathogens compared with the NP/OP spec-
imens from the controls (Supplemental Table 4) is an impor-
tant limitation of this analysis and suggests that a proportion 
of subjects in the nonpneumonia group were hospitalized with 
clinically milder respiratory illness. An additional limitation to 
this analysis is that the nonpneumonia group was not equally 
represented across sites.
The prevalence of individual viral and bacterial organisms 
detected in IS specimens with molecular methods in the cur-
rent study is generally similar to that in recent reports by other 
investigators, although our ability to make comparisons with 
other studies is limited by differences in case definitions and 
laboratory methods. In a 2007–2008 study in China of children 
hospitalized with CAP with pneumonic infiltrates on chest radi-
ographs, a respiratory virus was detected with PCR in 272 of 
273 IS specimens from children with CAP (99.6%) and 80 of 81 
IS specimens (98.8%) from children with a chronic respiratory 
condition [17]. The most prevalent viruses in the IS specimens 
of children with CAP included rhinovirus (17.2%), human 
bocavirus (28%), RSV (37.4%), cytomegalovirus (92%), and 
several other human herpesviruses [17]. Although some viruses 
were detected more frequently in cases with CAP than in those 
without CAP, NP and OP specimens were not obtained, so it is 
not known whether the IS specimen would have added diag-
nostic value above and beyond an NP/OP specimen. In studies 
in Kenya and Finland, a respiratory pathogen was detected with 
PCR of IS specimens in more than half of children hospitalized 
with pneumonia, findings generally similar to those reported 
here, but with a few notable differences (eg, RSV was detected 
in 4% of cases in Finland, 16% in Kenya, and 25% in the current 
study) [13, 14, 16].
A separate analysis of all PERCH cases (not just those with 
radiographic pneumonia) reports that among 43 cases positive 
for Bordetella pertussis in whom both NP/OP and IS specimens 
(of any quality) were available, 14 (32.6%) were positive by IS 
but not NP/OP specimens, 2 (4.7%) were positive by NP/OP 
but not IS specimens, and 27 (62.8%) were positive by both [33], 
suggesting that IS specimens contribute substantial yield in the 
diagnosis of pertussis, a disease not of the lung parenchyma and 
not typically associated with radiographic changes. The added 
value in the detection of P. jirovecii was minimal in the HIV-
positive children with radiographic pneumonia; however, col-
lection of both IS and NP/OP specimens provides the highest 
yield and may be worthwhile to ensure proper diagnosis and 
treatment. Determination of infection versus colonization with 
P. jirovecii in these cases would require assessment of organism 
density and clinical correlation [34]. Although the diagnostic 
yield from an IS specimen may not be sufficient to justify this 
mildly invasive procedure as a routine part of the diagnostic 
workup for CAP, IS specimens are still important in cases with 
suspected tuberculosis and may also be useful in those in whom 
certain other pathogens (eg, B. pertussis, M. pneumoniae) are 
suspected. The lack of utility of bacterial cultures of IS speci-
mens in determining the cause of pneumonia in children <5 
years of age is reported on elsewhere [20].
Selection of specimens for detecting the potential cause(s) 
of pneumonia must balance epidemiological sensitivity against 
the feasibility, costs, and time required for specimen collection 
and data analysis. Collection of IS specimens is generally well 
tolerated [31]; however, collection and testing involves signifi-
cant costs and the impact of the additional detections in deter-
mining the cause of pneumonia is minimal for most pathogens.
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